GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.

We recently published 13 Best ADR Stocks to Invest In. GSK plc (NYSE:GSK) is one of the best ADR stocks. GSK plc (NYSE:GSK) ...

GSK secures FDA approval for Exdensur, the first twice-yearly biologic for treating severe asthma with an eosinophilic phenotype.

GSK plc (NYSE:GSK) is one of the best pharma stocks to invest in. J.P. Morgan analyst Richard Vosser maintained a Sell rating ...

The London-based pharmaceuticals firm explained the approval for Exdensur is as an add-on maintenance treatment of severe asthma "characterised by an eosinophilic phenotype" in both adult and ...

GSK plc (NYSE:GSK) is one of the best undervalued stocks to buy under $50. Deutsche Bank analyst Emmanuel Papadakis released a rating update for GSK plc (NYSE:GSK), maintaining a Hold rating on the ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the fund declined ...

Shares of GSK PLC GSK slipped 1.15% to £18.05 Friday, on what proved to be an all-around poor trading session for the stock ...

GSK plc is a multinational “big pharma” and long-time leader in the vaccine, HIV, and respiratory disease areas. Shingrix and RSV vaccine sales in 2023 exceeded expectations and appear to show no sign ...

GSK investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: According to the filed complaint, defendants represented to ...

Fintel reports that on October 23, 2025, JP Morgan Cazenove reiterated coverage of GSK plc - Depositary Receipt (NYSE:GSK) with a Underweight recommendation. As of September 30, 2025, the average ...

Aristotle Capital Management, LLC, an investment management company, released its “International Equity Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the ...